Exchange: NASDAQ·Updated 07:24 AM EDT
RNAC logo

RNAC Selecta Biosciences Inc

$9.10
$0.02
(0.22%)
Pre-Market
Prev Close $9.12
Reported EarningsAug 6
Mkt Cap$274.72M
Vol169.00

About RNAC

Cartesian Therapeutics, Inc. is a clinical-stage biotechnology company, which engages in mRNA cell therapies for the treatment of autoimmune diseases. It operates in research and development of cell therapy product candidates. The company was founded on December 10, 2007 is headquartered in Frederick, MD.
36

Bearish Sentiment

How do you feel about RNAC?

Advertisement|Remove ads.